Strategy for Uptake of Processes for Recognizing and Responding to Acute Kidney Injury
SUPPORT AKI
1 other identifier
interventional
2,135
1 country
4
Brief Summary
Acute kidney injury (AKI) is common and costly complication of major surgery. AKI can lead to prolonged hospitalization and a higher likelihood of dialysis, chronic kidney disease and death. However, AKI can be reversed when recognized early, by ensuring that patients receive adequate fluids and medications that worsen kidney function or cause toxicity are avoided or appropriately prescribed. Past research suggests that AKI in surgical settings can be missed early in its onset, leading to delayed intervention and progression to more severe stages. The purpose of this project is to implement clinical decision support for early recognition and management of AKI on surgical units in Alberta hospitals, and to determine whether the initiative leads to improvements in the quality of care for AKI, length of hospital stay for patients, and costs to the healthcare system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2018
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 13, 2018
CompletedFirst Submitted
Initial submission to the registry
May 25, 2018
CompletedFirst Posted
Study publicly available on registry
June 20, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedNovember 28, 2023
June 1, 2022
1.9 years
May 25, 2018
November 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Progression of AKI
Incidence of progression of AKI to higher AKI stage (including progression to dialysis or death)
From date of AKI onset to discharge from hospital, assessed up to 30 days
Secondary Outcomes (8)
Length of AKI hospital stay, days
From date of AKI onset to discharge from hospital, assessed up to 30 days
Resource use for AKI
Duration of index hospital admission, assessed up to 30 days
Time to initial response to AKI
From AKI onset up to 48 hours following AKI onset
Volume intervention (change in fluid or diuretic order) for AKI
Within 48 hours following AKI onset
Adverse medication exposure
Within 48 hours following AKI onset
- +3 more secondary outcomes
Study Arms (2)
SUPPORT AKI Clinical Decision Support
EXPERIMENTALMultidimensional clinical decision support intervention consisting of education and tools to support early recognition and management of AKI, including guidance on fluid therapies, medication management, investigation, and consultation with specialists.
Control
NO INTERVENTIONUsual care provided to patients with AKI on surgical units.
Interventions
Surgical units will receive a multidimensional clinical decision support intervention consisting of: (1) electronic and non-computerized tools to alert for early recognition of AKI, (2) educational program for physicians and nursing staff, (3) decision support tools with guidance on fluid therapies, medication management, investigations for AKI, and consultation with specialists.
Eligibility Criteria
You may qualify if:
- Adult patients (18 years of age and older) who develop hospital-acquired acute kidney injury on identified general and vascular surgery units in Alberta
You may not qualify if:
- Hospitalized on non-surgical units
- Receiving dialysis prior to admission on surgery unit
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Calgarylead
- Alberta Health servicescollaborator
- University of Albertacollaborator
- Covenant Health, Canadacollaborator
Study Sites (4)
Peter Lougheed Centre
Calgary, Alberta, T1Y6J4, Canada
Foothills Medical Centre
Calgary, Alberta, T2N2T9, Canada
University of Alberta Hospital
Edmonton, Alberta, T6G2B7, Canada
Grey Nuns Community Hospital
Edmonton, Alberta, T6L5X8, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew T James, MD, PhD
Associate Professor
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 25, 2018
First Posted
June 20, 2018
Study Start
March 13, 2018
Primary Completion
January 31, 2020
Study Completion
December 31, 2020
Last Updated
November 28, 2023
Record last verified: 2022-06